Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection [5]

Breast Journal

Volumn 11, Issue 2, 2005, Pages 158-159

  Komenaka, Ian K ^a   DeRaffele, Gail ^a   Hurst Wicker, Karl S ^a   Kaufman, Howard L ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ADULT; ANAMNESIS; ASPIRATION BIOPSY; BREAST METASTASIS; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; LETTER; MAMMOGRAPHY; MELANOMA; PHYSICAL EXAMINATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2; MASTECTOMY, SEGMENTAL; MELANOMA; PROGNOSIS; REMISSION INDUCTION; SKIN NEOPLASMS; TIME FACTORS;

EID: 15444372996     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21627.x     Document Type: Letter

References (5)

1. Alva S, Shetty-Alva N. An update of tumor metastasis to the breast data. Arch Surg 1999;134:450.
2. Morton DL, Hsueh EC, Essner R, et al. Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes. Ann Surg 2002;236:438-48.
3. Legha SS, Ring S, Papadopoulos N, Plager C, Chawla S, Benjamin R. A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma. Cancer 1989;64:2024-29.
4. Atkins MB, Lotze MT, Dutcher JP, et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol 1999;17:2105-16.
5. Spanknebel K, Hurst-Wicker K, Cheung K, et al. Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin-2. Ann Surg Oncol 2004;11:S77.